|
|
|
| Monday, October 29, 2012
|
|
4:00 PM - 7:00 PM
|
|
Regulatory Science: Perspectives
|
| Description: |
In a recent publication from the Institute of Medicine (IOM) entitled, “Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development”, the Food and Drug Administration (FDA) defines regulatory science as the “science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.” This symposium will include presentations by four of the leaders in the field of regulatory science:
Location:Merck Auditorium and Atrium (1st floor), 33 Avenue Louis Pasteur, Boston
Janet Woodcock, M.D. (FDA, Center for Drug Evaluation and Research)
Michael Rosenblatt, M.D. (Merck)
Elliott Antman, M.D. (Brigham and Women’s Hospital)
William Fisher, III, J.D., Ph.D. (Harvard Law School)
Following presentations, the audience will be invited to explore these topics further during an hour-long panel, moderated by Joshua Boger, Ph.D. The presentations and panel discussion will be followed by a reception to foster continued discussion. Members of the academic and pharmaceutical industries are welcome to attend.
For more information visit: http://catalyst.harvard.edu/news/news.html?p=4866&title=Register+now+for+Regulatory+Science%3A+Perspectives+–+Part+of+the+Kantoff-Sang+Lecture+Series
|
| Contact: |
Eva Konomi
|
|
| Tuesday, October 30, 2012
|
|
12:30 PM - 1:30 PM
|
|
|
4:00 PM - 5:00 PM
|
|
26th Apffel Memorial Lecture
|
| Description: |
Title: Cancel Cell Signaling and Metabolism: Integrated Networks with Emerging Implications for Cancer Therapy
Speaker: Robert T. Abraham, Ph.D., Senior Vice President and Chief Scientific Officer Oncology Research Unit, Pfizer
Location: Beth Israel Deaconess Medical Center Cancer Center Conference Room, Center for Life Science CLS 421
Light reception will follow the lecture in the CLS Lobby
For more information, contact Dr. Antoine Karnoub at akarnoub@bidmc.harvard.edu
|
| Contact: |
Cristina Bonilla
|
|
| Wednesday, October 31, 2012
|
|
Noon - 1:00 PM
|
|
|
2:00 PM - 3:20 PM
|
|
Circadian Clock in Development and Aging: No Time To Lose
|
| Description: |
Irina V. Zhdanova, M.D., Ph.D., Professor of Anatomy and Neurobiology, and Principal Investigator in the Laboratory of Sleep and Circadian Physiology at Boston University School of Medicine
Building R-103, Boston University
Note: Free and open to the public. Refreshments will be served on the sixth floor of the R Building at 1:45 P.M.
|
| Contact: |
Christina Cherel
|
|
| Thursday, November 1, 2012
|
|
8:30 AM - 4:00 PM
|
|
ALS TDI Leadership Summit
|
| Description: |
This free event aims to illuminate the latest trends in preclinical and clinical research for neurodegeneration and the converging roles of the patient, foundation and pharmaceutical company. It provides an intimate setting for innovative researchers from the bench and bedside to present their latest research findings and to make provocative and bold assessments of the state of ALS research. For more information or to register, please visit: http://www.als.net/ALS-Events/Summit/
|
| Contact: |
Mari Sullivan
|
|
|
12:15 PM
|
|
Systems Biology Seminar
|
| Description: |
Honghuang Lin, Research Assistant Professor Boston University School of Medicine
All talks to be held in LSE room 103, Boston University, 24 Cummington St., Boston, MA.
A free lunch will begin at 12:15; talks will begin at 12:45 unless otherwise noted.
|
| Contact: |
Paige Fults
|
|
| Friday, November 2, 2012
|
|
8:30 AM - 9:30 AM
|
|
|
8:30 AM - 9:30 AM
|
|
 |
|
|
Week of Sunday, October 28, 2012
